Abide Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Abide Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH366484D
  • |
  • Pages: 20
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Abide Therapeutics Inc (Abide) is a healthcare company that develops innovative therapies. The company offers endocannabinoid system that includes the cannabinoid receptors for the effects of both marijuana and natural ligands. It develops small-molecule inhibitor of MGLL, ABX-1431, that controls the magnitude of endogenous cannabinoid signaling by augmenting the levels of the endocannabinoid 2-AG. Abide's platform includes a proprietary chemical library, which is designed to interact with serine hydrolases and chemoproteomics. The company develops therapies for central and peripheral inflammation, chronic and neuropathic pain, and metabolic disease. Abide is headquartered in San Diego, California, the US.

Abide Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Abide Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Abide Therapeutics Raises USD6.6 Million in Series A Financing 10

Abide Therapeutics Raises USD2.2 Million in Seed Financing 10

Partnerships 11

Celgene Exercises its Option Agreement with Abide Therapeutics 11

Abide Therapeutics Enters Into Drug Discovery Agreement With Celgene 12

Abide Therapeutics Enters Into Co-Development Agreement With Merck 13

Abide Therapeutics Inc-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Corporate Communications 18

Jan 19, 2016: Abide Therapeutics Appoints Richard N. Kender to Board of Directors 18

Clinical Trials 19

May 10, 2016: Abide Therapeutics Announces First Subject Dosed In PET Occupancy Study with [18F]ABX-1488, a Proprietary Human Monoacylglycerol Lipase (MGLL)-Specific PET Ligand 19

Appendix 20

Methodology 20

About GlobalData 20

Contact Us 20

Disclaimer 20

List of Figures

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

List of Tables

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 1

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Abide Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Abide Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Abide Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Abide Therapeutics Raises USD6.6 Million in Series A Financing 10

Abide Therapeutics Raises USD2.2 Million in Seed Financing 10

Celgene Exercises its Option Agreement with Abide Therapeutics 11

Abide Therapeutics Enters Into Drug Discovery Agreement With Celgene 12

Abide Therapeutics Enters Into Co-Development Agreement With Merck 13

Abide Therapeutics Inc, Key Competitors 15

Abide Therapeutics Inc, Key Employees 16

Abide Therapeutics Inc, Other Locations 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16143
Site License
USD 500 INR 32285
Corporate User License
USD 750 INR 48428

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com